Ergo Science EBITDA Margin 1971-1970 | ERGN

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Ergo Science (ERGN) over the last 10 years. The current EBITDA margin for Ergo Science as of January 01, 1970 is .
Ergo Science EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
Sector Industry Market Cap Revenue
Business Services Business Information Services $0.000B $0.000B
ERGO SCIENCE CORP. is developing novel treatments for metabolic and immune system disorders including Type II diabetes and obesity.
Stock Name Country Market Cap PE Ratio
Recruit Holdings (RCRUY) Japan $88.150B 13.26
Experian (EXPGY) Ireland $47.147B 0.00
Verisk Analytics (VRSK) United States $37.022B 38.46
Iron Mountain (IRM) United States $26.566B 49.20
TransUnion (TRU) United States $17.707B 25.11
FactSet Research Systems (FDS) United States $14.817B 23.52
Morningstar (MORN) United States $10.966B 29.65
INTERTEK GP (IKTSY) United Kingdom $9.874B 0.00
Dun & Bradstreet Holdings (DNB) United States $4.067B 10.35
National Research (NRC) United States $0.323B 13.49
UCloudlink Group (UCL) Hong Kong, SAR China $0.105B 30.89
YSX Tech (YSXT) China $0.066B 0.00
Click Holdings (CLIK) Hong Kong, SAR China $0.011B 0.00
36Kr Holdings (KRKR) China $0.010B 0.00